Unfortunately this company shows week after week it does not know how to deal properly with a potential successful public company. It appears its being managed as a little private company. The CEO , if qualified, needs to start acting as a CEO and not somebody that takes everything personal !! It comes with the territory and you become a target of opinions just like mine !! If you feel you need to defend yourself deliver the value , be effective with news and follow up on PR's. The current pps is a direct result of delays, integrity and lack of trust. The way some legit shareholders/boardmembers have been treated is unacceptable and doesnt show much class. Hopefully potential acquisitions and board meetings are not conducted this way. I have serious concerns the silence is not good news but hopefully Im wrong........prove me wrong and I will apologize for my post if you hit the two digits !!
I assume Funding, institutional buying, Altucell closing, Q2, divi issue resolved, China deal, acquisitions , Barda, AE37 trial and a few other events are all on track or completed ??? To be "big pharma" with 8 GNBT employees sounds like a lean mean machine to me !!
Im here because I still believe in the company !!